98-26571. Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 63, Number 192 (Monday, October 5, 1998)]
    [Notices]
    [Page 53445]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-26571]
    
    
    
    [[Page 53445]]
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Circulatory System Devices Panel of the Medical Devices Advisory 
    Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA).The meeting will be 
    open to the public.
        Name of Committee: Circulatory System Devices Panel of the Medical 
    Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on October 27, 1998, 8 a.m. 
    to 5 p.m.
        Location: Hilton Hotel, Salons C, D, and E, 620 Perry Pkwy., 
    Gaithersburg, MD.
        Contact Person: John E. Stuhlmuller, Center for Devices and 
    Radiological Health (HFZ-450), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-443-8243, ext. 157, or FDA 
    Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
    the Washington, DC area), code 12625. Please call the Information Line 
    for up-to-date information on this meeting.
        Agenda: The committee will discuss, make recommendations, and vote 
    on a premarket approval application for a transmyocardial 
    revascularization device.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by October 16, 
    1998. Oral presentations from the public will be scheduled between 
    approximately 8 a.m. and 8:30 a.m. Near the end of committee 
    deliberations, a 30-minute open public hearing will be conducted for 
    interested persons to address issues specific to the topics before the 
    committee. Time allotted for each presentation may be limited. Those 
    desiring to make formal oral presentations should notify the contact 
    person before October 16, 1998, and submit a brief statement of the 
    general nature of the evidence or arguments they wish to present, the 
    names and addresses of proposed participants, and an indication of the 
    approximate time requested to make their presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: September 28, 1998.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 98-26571 Filed 10-2-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
10/05/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-26571
Pages:
53445-53445 (1 pages)
PDF File:
98-26571.pdf